【International Genomic Medicine Symposium - Panel 4】   Building on the momentum of the Symposium, Panel 4 explored how innovative access pathways and artificial intelligence (AI) are advancing rare disease care. Prof Gareth Baynam and Prof Yong Chen shared insightful perspectives on turning these innovations into real‑world impact for patients. 🌍✨   💬 Session Chairperson: Prof Lau Chak‑sing, BBS, JP Vice‑President & Pro‑Vice‑Chancellor (Health) HKUMed – The University of Hong Kong Board Member, Hong Kong Genome Institute Hong Kong, China   📌 Topic 1: UTOPIA: Unlocking Treatment Options, Personalised In‑Time Access  🗣️ Prof Gareth Baynam Medical Director Rare Care Centre, Perth Children’s Hospital Australia   📌 Topic 2: Modernizing Rare Diseases Studies with AI  🗣️ Prof Yong Chen Professor of Biostatistics, University of Pennsylvania USA   🎥 Watch the full session: https://lnkd.in/gjmt5TFt   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|InternationalGenomicMedicineSymposium} {hashtag|\#|PrecisionMedicine} {hashtag|\#|ArtificialIntelligence} {hashtag|\#|GlobalHealth}

【𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗖𝗮𝗿𝗲 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗚𝗲𝗻𝗼𝗺𝗶𝗰 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻】   Rare diseases may affect small patient populations individually, but collectively they affect over 300 million people worldwide. To bridge the gap between scientific discovery and clinical care, we must move beyond individual breakthroughs towards a coordinated, technology-driven journey of care. 🏞️⚕️   We were honoured to participate in the 𝗔𝘀𝗶𝗮 𝗦𝘂𝗺𝗺𝗶𝘁 𝗼𝗻 𝗚𝗹𝗼𝗯𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 ({hashtag|\#|𝗔𝗦𝗚𝗛}), where our Chief Executive Officer, Dr Hon-Yin Brian Chung, chaired a pivotal session: “From Detection to Cure: Accelerating Innovations for Rare Diseases”. The discussion explored how genomic diagnostics, cell and gene therapies, and AI are redefining the patient experience. 🤖   “The key priorities are early patient involvement, multi-sector collaboration, and the thoughtful use of technology – not falling into the pitfall of solutions that don’t truly serve the diseases we aim to treat,” shared Dr Chung.    At HKGI, we remain dedicated to expanding the reach of genomic medicine, shortening the diagnostic odyssey, and ensuring that innovation translates into tangible outcomes for patients and their families. 💙   Our sincere thanks to the {hashtag|\#|𝗛𝗞𝗧𝗗𝗖} and fellow speakers for their visionary insights: Dr Francesco Cutrale, Dr Inna MENKOVA, Ms Rute Fernandes, Prof Leszek Lisowski, PhD, MBA, and Dr Zicai Liang.   {hashtag|\#|HKGI} {hashtag|\#|HKGP} {hashtag|\#|HongKongGenomeInstitute} {hashtag|\#|GenomicMedicine} {hashtag|\#|ASGH2026} {hashtag|\#|RareDiseases} {hashtag|\#|Innovation} {hashtag|\#|PrecisionMedicine} {hashtag|\#|HealthTech} {hashtag|\#|HKTDC} {hashtag|\#|AsiaSummitOnGlobalHealth}

【International Genomic Medicine Symposium - Panel 3】   How do we bridge the gap between a laboratory discovery and global clinical practice? ✍️🧬   Panel 3 of our Symposium turned the spotlight on the critical role of medical publishing. The session explored the challenges and opportunities in research dissemination, with Dr Chloe Wilson, Senior Medical Editor at The Lancet, sharing insights on communicating scientific findings effectively to a global audience.    💬 Session Chairperson Prof Philip Chiu, JP CUHK Medicine Hong Kong, China   📌 Topic: Medical Publishing: Challenges and Opportunities  🗣️Speaker:  Dr Chloe Wilson Senior Medical Editor, The Lancet Group   🎥 Watch the full session: https://lnkd.in/gGTb3cFb   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|InternationalGenomicMedicineSymposium} {hashtag|\#|PrecisionMedicine} {hashtag|\#|MedicalPublishing} {hashtag|\#|ScientificCommunication}

【International Genomic Medicine Symposium – Patient Voices & Perspectives】   Science and empathy go hand in hand. 🧬✨   The Symposium spotlighted patient voices and community perspectives. Ms Alexandra Heumber Perry, then Chief Executive Officer of RARE DISEASES INTERNATIONAL, shared global patient insights and underscored the importance of equitable access and international collaboration to ensure that scientific advances translate into meaningful real-world impact. 💬🌍   📌 Patient Voices & Perspectives 🗣️ Speaker: Ms Alexandra Heumber Perry Then Chief Executive Officer, Rare Diseases International   🎥 Watch the full session: https://lnkd.in/g7JArBhT   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|InternationalGenomicMedicineSymposium} {hashtag|\#|PatientVoices} {hashtag|\#|RareDiseases} {hashtag|\#|GlobalHealth} {hashtag|\#|RDI}

【🎉 Celebrating 6 Years of HKGI: Advancing Genomic Medicine in Hong Kong 🎉】   Today, we proudly mark the 6th anniversary of HKGI — a milestone that reflects our shared commitment to advancing genomic medicine and improving health outcomes for the community.   Over the years, HKGI has made significant strides in building a strong foundation for precision medicine in Hong Kong.   🔬 Expanding the Hong Kong Genome Project (HKGP) We have successfully recruited over 60,000 participants across 12 public hospitals, accelerating the integration of genomics into clinical care and research. The HKGP has also achieved a diagnostic yield of 25% in identifying pathogenic variants for cases of undiagnosed disorders.  🤝 Nurturing Talent and Empowering the Community We have actively nurtured talent through targeted engagement initiatives for healthcare professionals, researchers, students and the public. These efforts have not only enhanced genomic literacy and clinical capabilities but also fostered greater community awareness and understanding of genomic medicine.   Our progress is made possible by the dedication of our partners, collaborators, and participants, who share our vision for the future of healthcare.   Looking ahead, HKGI will continue to integrate genomic medicine into clinical care, advance research, nurture talent, and strengthen public genomic literacy and industry partnerships — shaping a healthier future for Hong Kong and beyond, together.   💚 Thank you for being part of our journey.   {hashtag|\#|HKGI} {hashtag|\#|HKGP} {hashtag|\#|HongKongGenomeProject} {hashtag|\#|GenomicMedicine} {hashtag|\#|PrecisionMedicine} {hashtag|\#|HealthcareInnovation} {hashtag|\#|HKGIAnniversary}

【International Genomic Medicine Symposium - Panel 1】   At the International Genomic Medicine Symposium, experts from around the world came together to share perspectives on how genomic medicine continues to shape clinical practice.   Panel 1 explored how advances in understanding molecular pathogeneses are translating into better patient care. Prof Kym Boycott shared insights from her work in rare diseases, highlighting how advances at the molecular level translate into tangible benefits for patients and their families. ⭐ 💬 Session Chairperson: Dr Ronald Lam, JP Director of Health, Hong Kong SAR Government Hong Kong, China 📌Topic 1: Unraveling Molecular Pathogeneses to Enhance Patient Care and Family Well‑being 🗣️ Speaker: Prof Kym Boycott Co‑Chair, Lancet Commission on Rare Diseases Professor of Pediatrics, University of Ottawa Canada   🎥 Watch the full panel discussion: https://lnkd.in/gUxWWCzr Stay tuned for more panel highlights. 💡   {hashtag|\#|HKGI} {hashtag|\#|GenomicMedicine} {hashtag|\#|HKGP} {hashtag|\#|GenomeProject} {hashtag|\#|PrecisionMedicine} {hashtag|\#|RareDiseases} {hashtag|\#|InternationalGenomicMedicineSymposium}